Professor Michel Goldman of the Innovative Medicines Intiative (IMI) will speak in a panel on How to Finance Innovation? on the 15th of May at the 12th European Business Summit.
Michel Goldman, Executive Director of IMI, builds and promotes networks of innovation, in close collaboration with all stakeholders involved in pharmaceutical R&D. IMI supports the launch and successful continuation of collaborative programmes to foster research and development activities on more effective and safer therapies for patients across Europe.
Michel Goldman is Professor of Immunology at the Faculty of Medicine of the Université Libre de Bruxelles, Belgium. His achievements in the fields of immune-mediated disorders and immune-based biotherapies resulted in more than 400 articles.
In 2000, Michel Goldman received the Joseph Maisin Prize, a major award for clinical sciences delivered by the Belgian Fund for Scientific Research, and he held the Spinoza chair at the University of Amsterdam in 2001. He was recognized as an ISI Highly Cited Scientist by the Thomson Institute for Scientific Information in 2006. Michel Goldman was awarded the degree of Doctor Honoris Causa of the Université Lille II, France in 2007.
For more information on Michel Goldman and IMI, please visit: http://www.imi.europa.eu/